Literature DB >> 15947668

Passerini-glazel feminizing genitoplasty: a long-term followup study.

Aldo Bocciardi1, Arianna Lesma, Francesco Montorsi, Patrizio Rigatti.   

Abstract

PURPOSE: We report our experience with early 1-stage Passerini-Glazel feminizing genitoplasty with special emphasis on long-term results of vaginoplasty.
MATERIALS AND METHODS: A total of 66 patients with ambiguous genitalia underwent 1-stage Passerini-Glazel feminizing genitoplasty. Long-term followup included an outpatient visit at 1 year postoperatively and a genital assessment with the patient under general anesthesia performed before menarche courses in those operated on at age 6 months to 8 years, and at 2 years postoperatively for those operated on at 9 years or older.
RESULTS: All patients underwent the first long-term followup evaluation and no major complications were observed. The second long-term followup evaluation was performed in 46 patients (70%). In all cases the vaginal introitus was located in the physiological position and was large and elastic. Vaginal caliber at the suture line between the tubularized flap and vaginal mucosa was the same size as the vaginal introitus and distal native vagina in 20 of 46 patients (43%), slightly smaller in 10 (22%) and stenotic in 16 (35%). Stenosis at the suture line was corrected with simple Y-V introitoplasty performed at the same followup visit.
CONCLUSIONS: Early 1-stage Passerini-Glazel feminizing genitoplasty is a safe and effective procedure that allows total surgical correction of ambiguous genitalia in infancy and good cosmetic results. Incidence of vaginal stenosis at the suture line is high but it can be repaired with simple introitoplasty performed before menarche occurs. Good functional results are presumed.

Entities:  

Mesh:

Year:  2005        PMID: 15947668     DOI: 10.1097/01.ju.0000161211.40944.87

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  7 in total

Review 1.  Feminizing surgery for disorders of sex development: evolution, complications, and outcomes.

Authors:  Richard S Hurwitz
Journal:  Curr Urol Rep       Date:  2011-04       Impact factor: 3.092

2.  Consensus in Guidelines for Evaluation of DSD by the Texas Children's Hospital Multidisciplinary Gender Medicine Team.

Authors:  Ganka Douglas; Marni E Axelrad; Mary L Brandt; Elizabeth Crabtree; Jennifer E Dietrich; Shannon French; Sheila Gunn; Lefkothea Karaviti; Monica E Lopez; Charles G Macias; Laurence B McCullough; Deepa Suresh; V Reid Sutton
Journal:  Int J Pediatr Endocrinol       Date:  2010-10-17

3.  Long-term follow-up after feminizing genital reconstruction in patients with ambiguous genitalia and high vaginal confluence.

Authors:  Sungchan Park; Seong Heon Ha; Kun Suk Kim
Journal:  J Korean Med Sci       Date:  2011-02-25       Impact factor: 2.153

4.  Long-term outcome of genital reconstruction of Middle Eastern women with congenital adrenal hyperplasia.

Authors:  Raouf M Seyam; Nabil K Bissada; Mohamed Abdul-Aaly; Nadia A Sakati; Waleed Al Taweel; Waleed K Alkhudair
Journal:  Urol Ann       Date:  2013-10

5.  Managing disorder of sexual development surgically: A single center experience.

Authors:  Jatinder Kumar; Vikas Kumar; Vijaylakshmi Bhatia; Preeti Dabadghao; Samit Chaturvedi; Rakesh Kapoor; M S Ansari
Journal:  Indian J Urol       Date:  2012-07

6.  Preliminary report: Surgical outcomes following genitoplasty in children with moderate to severe genital atypia.

Authors:  K J Bernabé; N J Nokoff; D Galan; D Felsen; C E Aston; P Austin; L Baskin; Y-M Chan; E Y Cheng; D A Diamond; R Ellens; A Fried; S Greenfield; T Kolon; B Kropp; Y Lakshmanan; S Meyer; T Meyer; A M Delozier; L L Mullins; B Palmer; A Paradis; P Reddy; K J Scott Reyes; M Schulte; J M Swartz; E Yerkes; C Wolfe-Christensen; A B Wisniewski; D P Poppas
Journal:  J Pediatr Urol       Date:  2018-02-02       Impact factor: 1.921

7.  Feminizing genital reconstruction in congenital adrenal hyperplasia.

Authors:  Jeffrey A Leslie; Mark Patrick Cain; Richard Carlos Rink
Journal:  Indian J Urol       Date:  2009-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.